Cite
HARVARD Citation
Vergote, I. et al. (n.d.). 358 Phase 3 trial of tumor treating fields concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: ENGOT-ov50/GOG-329/INNOVATE-3. International journal of gynecological cancer. pp. A147-A148. [Online].